AAAAAA
Results:
1-8
|
Results: 8
Authors:
Gore, SD
Weng, LJ
Zhai, S
Figg, WD
Donehower, RC
Dover, GJ
Grever, M
Griffin, CA
Grochow, LB
Rowinsky, EK
Zabalena, Y
Hawkins, EK
Burks, K
Miller, CB
Citation: Sd. Gore et al., Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia, CLIN CANC R, 7(8), 2001, pp. 2330-2339
Authors:
Chui, DHK
Dover, GJ
Citation: Dhk. Chui et Gj. Dover, Sickle cell disease: no longer a single gene disorder, CURR OP PED, 13(1), 2001, pp. 22-27
Authors:
Chang, YPC
Littera, R
Garau, R
Smith, KD
Dover, GJ
Iannelli, S
Cacace, E
Contu, L
Citation: Ypc. Chang et al., The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia, BR J HAEM, 114(4), 2001, pp. 899-906
Authors:
Bogen, DL
Duggan, AK
Dover, GJ
Wilson, MH
Citation: Dl. Bogen et al., Screening for iron deficiency anemia by dietary history in a high-risk population, PEDIATRICS, 105(6), 2000, pp. 1254-1259
Authors:
Dover, GJ
Citation: Gj. Dover, A new look at neuropathology in sickle cell disease, ANN NEUROL, 45(3), 1999, pp. 277-278
Authors:
Ballas, SK
Marcolina, MJ
Dover, GJ
Barton, FB
Citation: Sk. Ballas et al., Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea, BR J HAEM, 105(2), 1999, pp. 491-496
Authors:
Atweh, GF
Sutton, M
Nassif, I
Boosalis, V
Dover, GJ
Wallenstein, S
Wright, E
McMahon, L
Stamatoyannopoulos, G
Faller, DV
Perrine, SP
Citation: Gf. Atweh et al., Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease, BLOOD, 93(6), 1999, pp. 1790-1797
Authors:
Bilenker, JH
Weller, WE
Shaffer, TJ
Dover, GJ
Anderson, GF
Citation: Jh. Bilenker et al., The costs of children with sickle cell anemia: Preparing for managed care, J PED H ONC, 20(6), 1998, pp. 528-533
Risultati:
1-8
|